Evexia Lifecare Ltd

Evexia Lifecare Limited informed the BSE that its board of directors approved the conversion of 50 foreign currency convertible bonds into equity shares at a meeting held on September 11, 2026, following approval from shareholders at the Annual General Meeting on July 9, 2022.

EVEXIA LIFECARE LIMITED has informed the BSE that the record date for the purpose of Notice and e-voting for its 35th Annual General Meeting, to be held on September 30, 2026, is set as September 4, 2026, and September 25, 2026, respectively, for equity security holders.

EvExia LifeCare Limited informed the BSE that its board approved the company's report for the year ended March 31, 2026, and fixed the date, time, and place for the 35th Annual General Meeting to be held on Wednesday, September 30, 2026, at 3:00 p.m. IST via video conferencing or other audio visual means, with a book closure from Thursday, September 24, 2026, to Wednesday, September 30, 2026, and appointed M/s. Brajesh Gupta & Co as scrutinizer for the meeting.

Evexia Lifecare Ltd share price ticked higher by 4.20% to Rs 1.49. The Company's net profit plunged by 46.15% to Rs 0.42 crore, while revenue from operations declined 16.04% to Rs 30.89 crore in Q2FY26 over Q1FY26. The market capitalization of Trading - Chemicals industry group stocks on BSE stood at Rs 3560.14 crore, tanking 28.27%. It has eased by 1.59% over last one week and dropped by 13.64% in last one month while the market capitalization of Evexia Lifecare Ltd has softened by 0.67% and 23.14% in the same period respectively. Profit before tax (PBT) of Evexia Lifecare Ltd stood at Rs 0.57 crore in Q2 FY26, plunging by 33.72% year-on-year, and nosediving by 36.67% quarter-on-quarter. EBITDA came in at Rs 0 crore, tumbling by 64.49% YoY and crashing by 62.00% sequentially. Total expenses dropped by 15.31% to Rs 30.47 crore in Q2FY26 over Q2FY25. During the quarter, cost of materials consumed stood at Rs 0.04 crore, remained flat YoY, while employee benefits expense was at Rs 0.06 crore, collapsing by 82.86% YoY. For the TTM ended FY26, revenue from operations fell 19.07% to Rs 56.29 crore, while net profit surged by 105.97% to Rs 1.38 crore, compared to previous TTM. EBITDA tumbled by 227% to Rs 1.11 crore, and PBT witnessed a strong rise of 26.14% to Rs 1.93 crore compared to previous TTM. The company's consolidated net cash flow from operating activities stood at Rs 17.02 crore in FY26, as against Rs 3.15 crore in FY25. Evexia Lifecare Ltd crashed 37.28% in last one year, underperforming the benchmark BSE Sensex which has softened by 1.97% during the same period.

Evexia Lifecare Limited will hold a board meeting on Friday, August 07, 2026, to consider and approve audited financial results (standalone & consolidated) for the quarter ended June 30, 2026, according to a filing with the BSE Ltd. The trading window closure period will end 48 hours after the results are made public.

Net profit of Evexia Lifecare rose 151.61% to Rs 0.78 crore in the quarter ended March 2026 as against Rs 0.31 crore during the previous quarter ended March 2025. Sales rose 55.82% to Rs 36.79 crore in the quarter ended March 2026 as against Rs 23.61 crore during the previous quarter ended March 2025. For the full year,net profit rose 295.12% to Rs 1.62 crore in the year ended March 2026 as against Rs 0.41 crore during the previous year ended March 2025. Sales rose 27.34% to Rs 110.28 crore in the year ended March 2026 as against Rs 86.60 crore during the previous year ended March 2025. ParticularsQuarter EndedYear EndedMar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var. Sales36.7923.61 56 110.2886.60 27 OPM %3.025.55 -2.601.86 - PBDT1.200.91 32 2.861.39 106 PBT0.900.44 105 2.200.92 139 NP0.780.31 152 1.620.41 295 Powered by Capital Market - Live

Evexia Lifecare will hold a meeting of the Board of Directors of the Company on 9 May 2026.

Evexia Lifecare announced that the 34th Annual General Meeting(AGM) of the company will be held on 15 May 2026.

Net profit of Evexia Lifecare rose 141.67% to Rs 0.29 crore in the quarter ended December 2025 as against Rs 0.12 crore during the previous quarter ended December 2024. Sales rose 16.31% to Rs 25.24 crore in the quarter ended December 2025 as against Rs 21.70 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var. Sales25.2421.70 16 OPM %0.990.78 - PBDT0.510.27 89 PBT0.390.16 144 NP0.290.12 142 Powered by Capital Market - Live

Evexia Lifecare will hold a meeting of the Board of Directors of the Company on 14 February 2026.Powered by Capital Market - Live